Invest with Y122
N/A
Typical Investment
5
Expected Deals/Year
0
Unique LPs have invested
Note from Y122

Visit year122.com for more info on us, our events, and the newest longevity research.

We invest in companies trying to solve the most pervasive human problem, death. We're lifelong biohackers that have been in this space both professionally and personally for over a decade and saw a gap in venture we feel fit to fill. With the right technologies and teams, longevity is a full proof investment opportunity because


1. The addressable market size is everyone. Not just people 65+. Longevity can and should start being solved at a young age. Everyone dies, most everyone cares and thinks about this. Warren Buffett said it right, “You have only one mind and one body for the rest of your life. If you aren’t taking care of them when you’re young, it’s like leaving that car out in hailstorms and letting rust eat away at it. By the time you’re 40 or 50, you’ll be like a car that can’t go anywhere.”


2. The market that cares the most is growing, and the concentration of wealth is moving with them. By 2030, all baby boomers will be older than age 65, expanding the senior citizen age group to 1 in every 5 Americans. In just two decades, older people would outnumber children for the first time in U.S. history. Americans over 50 accounted for $7.6 trillion in direct consumer spending and related economic activity in 2015, and controlled more than 80% of household wealth. Global spending power of those age 60 and over will reach $15 trillion annually by 2020.


3. It doesn't need to be complicated to make a difference. The levers we have to extend healthspan and lifespan are within our power now. The best strategy we have today to study longevity is to look at centenarians. These people die from the same top causes as the general population—The Big Three. Cardiovascular disease, cancer, and neurodegenerative diseases. The difference is, the onset of these chronic illnesses are delayed for the centenarians. This means that even if we’re lucky to be born with longevity genes, we face the same fate as the general populous. The best way to extend life with the tools we have today is to delay the onset of The Big Three. What we know about chronic illnesses are that they are always progressive and almost always preventable. Progressive in that they begin developing before we feel symptoms. Preventable in that lifestyle factors we control today are their primary drivers.


4. Technology is ready. The key to developing effective technologies in this space is scalability and personalization. We're all unique, what gives you 5 more healthy years may not do the same for me. Scale is easily reached with today's software and personalization is improving with AI and consumer health data being captured from wearables, biomarker testing, Apple Health Kit, and more.



Dealflow

Through our years working in longevity and curating events in the space, we've built a community of relationships from which all deal sourcing and vetting comes from. All of our deals will be syndicated on Angellist.

Team
Kori Harrison
Founder
Longevity investor and product leader.
Investments
Private investments may not be included yet.
All deals on AngelList default to private. Learn More »
Raise money from value-add investors
One entry on your cap table
$0 Fees · 100% Private
Access to private deals
Invest with experienced angel investors
Over 200 active syndicates